The Insurance Prior Authorization Maze For platforms that prescribe brand-name GLP-1s, the primary administrative mechanism is the Prior Authorization (PA) process
More specifically, it is intended for individuals with a body mass index (BMI) above 30 kg/m2 (obese) or those with a BMI of 27 kg/m2 or greater (overweight) who have at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia
Ahlneck, C., & Zografi, G
Key points: Melanotan-II is being increasingly promoted on platforms like TikTok and YouTube The drug has been promoted as a product that can give its users a tan, but it can have serious health risks The TGA is targeting social media influencers and warning of big fines for people who are promoting dangerous products Last month the Therapeutic Goods Administration (TGA) issued a warning about Melanotan-II, a substance being widely spruiked on social media platforms such as TikTok and Instagram
Retatrutide targets GLP-1, GIP, and glucagon receptors simultaneously and is not yet licensed in the UK